A Guide for MedTech Innovators

Navigating the Regulatory Landscape: Is Your Technology a Medical Device?

For MedTech innovators, determining whether a new technology qualifies as a medical device is a critical first step. This classification dictates the regulatory pathway, market access strategy, and compliance obligations under the EU Medical Device Regulation (MDR 2017/745) and the In Vitro Diagnostic Regulation (IVDR 2017/746).

Defining a Medical Device

Under the MDR, a technology is classified as a medical device based on its intended purpose and primary mode of action. Specifically, a technology qualifies if it is intended for:

• Disease Management: Diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of disease.
• Injury or Disability: Diagnosis, monitoring, treatment, alleviation, or compensation for an injury or disability.
• Physiological Processes: The investigation, replacement, or modification of the anatomy or of a physiological or pathological process.
• Conception: The control or support of conception.

Crucially, the primary function of a medical device must not be achieved through pharmacological, immunological, or metabolic means, though it may be assisted by such means.

When Technology Falls Outside the MDR

Not all health-related technology is regulated as a medical device. A technology is generally not considered a medical device if:

• Its primary function is general wellness, such as fitness trackers or sleep monitors that do not make diagnostic claims.
• It is software without a medical function, such as administrative tools or appointment schedulers.
• It is a consumer technology with no clinical claims, like blue light glasses or massage chairs.

Navigating Borderline Cases and Software

The line between a digital tool and a medical device often blurs in "borderline cases" where the tool supports but does not directly drive clinical decisions. Clinical Decision Support (CDS) tools are a primary example.

Classification often depends on the level of automation:

• Exempt Tools: Dashboards or guidelines that merely present data or suggest options, leaving the full interpretation to the clinician, may be exempt.
• Regulated Tools: Tools that provide specific recommendations, prioritize actions, or use AI for treatment suggestions are more likely to be classified as medical devices. Under MDR Annex VIII (Rule 11), CDS tools used for diagnosis or therapy often fall into Class IIa or higher.

The Role of Clinical Trials and Endpoints

Innovators can use technology in clinical trials to generate evidence and validate performance without full CE marking. This allows for the collection of exploratory endpoints, measurable outcomes used to assess an intervention's effect.

In a research-only context, if the outputs are used in aggregate for safety or efficacy assessment and are not used to diagnose, treat, or monitor participants during the trial, the tool may fall outside the MDR scope. The intended purpose remains the decisive factor: if a tool is explicitly designed for research or hypothesis generation rather than clinical management, it is not a medical device, regardless of its technical capabilities.

Conclusion

Regulatory oversight aligns strictly with intended use rather than validation status alone. While a tool might process health data, it only becomes a regulated medical device when it claims to influence clinical decisions or patient management. Understanding these distinctions early allows innovators to engage regulators and collect necessary data through appropriate pathways.

To learn more, or discuss your specific case with DEEP Regulatory experts, contact us here.